Clinical Trial Update: A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease [Phase 4]

View source ↗

Summary

A Phase 4 interventional study evaluating the clinical and operational effectiveness of transitioning from Mircera to Daprodustat for the treatment of anemia in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease
• End-stage Kidney Disease
• Renal Anemia

Drugs mentioned

• Daprodustat (daprodustat)
• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: USRC Kidney Research | Conditions: Anemia, Renal Insufficiency, Chronic | Phase 4 | Status: COMPLETED